Granulocyte-macrophage colony stimulating factor (GM-CSF)
Showing 1 - 25 of >10,000
Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)
Recruiting
- Recurrent Osteosarcoma
- humanized anti-GD2 antibody
- GM-CSF
-
Los Angeles, California
- +2 more
Dec 22, 2022
Renal Cancer Trial in Boston (Dendritic Cell Tumor Fusion Vaccine, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF))
Active, not recruiting
- Renal Cancer
- Dendritic Cell Tumor Fusion Vaccine
- Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 2, 2023
Neuroblastoma Trial in New York (Hu3F8 With GM-CSF)
Active, not recruiting
- Neuroblastoma
- Hu3F8 With GM-CSF
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 2, 2022
Breast Cancer Trial in Boston (Autologous, Lethally Irradiated Breast Cancer Cells)
Completed
- Breast Cancer
- Autologous, Lethally Irradiated Breast Cancer Cells
-
Boston, Massachusetts
- +1 more
Mar 30, 2022
Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +8 more
-
Los Angeles, CaliforniaUSC CRS
Oct 26, 2021
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)
Recruiting
- Neuroblastoma
- Naxitamab monotherapy
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 31, 2023
Severe Acute Respiratory Syndrome (SARS) Pneumonia, COVID-19 Pneumonia Trial in Germany (Molgramostim nebuliser solution,
Active, not recruiting
- Severe Acute Respiratory Syndrome (SARS) Pneumonia
- COVID-19 Pneumonia
- Molgramostim nebuliser solution
- Placebo nebuliser solution
-
Dresden, Germany
- +8 more
Jun 20, 2022
IVF, PCOS, IVM Trial in Ho Chi Minh City (GM-CSF group, Control group)
Recruiting
- IVF
- +2 more
- GM-CSF group
- Control group
-
Ho Chi Minh City, VietnamMy Duc Hospital
Jul 12, 2021
Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial in Boston (GM-CSF, Dendritic Cell/Tumor Fusion Vaccine,
Active, not recruiting
- Ovarian Cancer
- +2 more
- GM-CSF
- +2 more
-
Boston, Massachusetts
- +3 more
Jan 25, 2022
Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)
Terminated
- Hepatitis B, Chronic
- Granulocyte Macrophage-colony Stimulating Factor
- Entecavir
-
Beijing, Beijing, China302 Military Hospital
Mar 9, 2022
Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)
Recruiting
- Thymoma
- Radiotherapy Combined with GM-CSF
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 2, 2022
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Thymalfasin, Radiotherapy, PD-1/PD-L1 inhibitor)
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Thymalfasin
- +3 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Mar 29, 2023
Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)
Not yet recruiting
- Down Syndrome
- Sargramostim for Injection
- Saline Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 28, 2022
Neuroblastoma Recurrent Trial in Worldwide (Naxitamab and GM-CSF in combination with irinotecan and temozolomide)
Terminated
- Neuroblastoma Recurrent
- Naxitamab and GM-CSF in combination with irinotecan and temozolomide
-
Hong Kong, Hong Kong
- +2 more
Nov 8, 2022
ARDS Trial in Germany (inhaled molgramostim (rhGM-CSF), inhaled )
Active, not recruiting
- ARDS
- inhaled molgramostim (rhGM-CSF)
- inhaled placebo
-
Würzburg, Baden-Würtemberg, Germany
- +6 more
Oct 27, 2021
HIV Trial in United States (APL 400-047, ALVAC-HIV MN120TMG (vCP205), Sargramostim)
Completed
- HIV Infections
- APL 400-047
- +2 more
-
Birmingham, Alabama
- +3 more
Oct 28, 2021
Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)
Recruiting
- Alzheimer Disease
- Sargramostim
- Saline - placebo comparator
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 19, 2022
Neuroblastoma Trial in Worldwide (GM-CSF + Naxitamab)
Recruiting
- Neuroblastoma
- GM-CSF + Naxitamab
-
Gainesville, Florida
- +22 more
Aug 29, 2022
Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage
Recruiting
- Advanced Solid Tumor
- Refractory Tumor
- Radiotherapy
- +4 more
-
Suzhou, ChinaThe Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI
Completed
- Myelodysplastic Syndrome (MDS)
- +2 more
- WT1:126-134
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 1, 2022
Hereditary Pulmonary Alveolar Proteinosis Trial in Cincinnati, Richmond (Leukine)
Completed
- Hereditary Pulmonary Alveolar Proteinosis
-
Cincinnati, Ohio
- +1 more
Aug 31, 2020